drugset / Trial / NCT03863002
Safety and Efficacy of Mesenchymal Stem Cell Transplantation for Acute-on-Chronic Liver Failure
RandomizedParallel-groupOpen-labelTreatment
Summary
Safety and Efficacy of Mesenchymal Stem Cell Transplantation for Acute-on-Chronic Liver Failure
Timeline
- Start
- 2019-10-01
- Primary completion
- 2021-10-01
- Completion
- 2022-10-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mesenchymal stem cell | Cell therapy | 100000 cells/kg | Intravenous |
| Subject | Mesenchymal stem cell | Cell therapy | 1e+06 cells/kg | Intravenous |